CARMUSTINE RAZ 100 MG Израел - Енглески - Ministry of Health

carmustine raz 100 mg

raz pharmaceutics ltd, israel - carmustine - powder and solvent for concentrate for solution for infusion - carmustine 100 mg - carmustine - carmustine is indicated as palliative therapy as a single agent or in established combination therapy with other approved agents in the following:• brain tumors - glioblastoma, medulloblastoma, astrocytoma and metastatic brain tumors.• multiple myeloma - in combination with glucocorticoid such as prednisone. • hodgkin’s disease - as secondary therapy in combination with other approved drugs in patients who relapse while being treated with primary therapy, or who fail to respond to primary therapy.• non-hodgkin’s lymphomas - as secondary therapy in combination with other approved drugs in patients who relapse while being treated with primary therapy, or who fail to respond to primary therapy.

Rigevidon tablets Велика Британија - Енглески - MHRA (Medicines & Healthcare Products Regulatory Agency)

rigevidon tablets

gedeon richter (uk) ltd - ethinylestradiol; levonorgestrel - oral tablet - 30microgram ; 150microgram

CARMUSTINE NAVINTA 100 MG Израел - Енглески - Ministry of Health

carmustine navinta 100 mg

mbi pharma ltd., israel - carmustine - powder and solvent for concentrate for solution for infusion - carmustine 100 mg/vial - carmustine - carmustine is indicated as palliative therapy as a single agent or in established combination therapy with other approved agents in the following:• brain tumors - glioblastoma, medulloblastoma, astrocytoma and metastatic brain tumors.• multiple myeloma - in combination with glucocorticoid such as prednisone. • hodgkin’s disease - as secondary therapy in combination with other approved drugs in patients who relapse while being treated with primary therapy, or who fail to respond to primary therapy.• non-hodgkin’s lymphomas - as secondary therapy in combination with other approved drugs in patients who relapse while being treated with primary therapy, or who fail to respond to primary therapy

CARMUSTINE OBVIUS Израел - Енглески - Ministry of Health

carmustine obvius

k.s.kim international ltd - carmustine - powder and solvent for concentrate for solution for infusion - carmustine 100 mg - carmustine - carmustine is indicated as palliative therapy as a single agent or in established combination therapy with other approved agents in the following:• brain tumors - glioblastoma, medulloblastoma, astrocytoma and metastatic brain tumors.• multiple myeloma - in combination with glucocorticoid such as prednisone. • hodgkin’s disease - as secondary therapy in combination with other approved drugs in patients who relapse while being treated with primary therapy, or who fail to respond to primary therapy.• non-hodgkin’s lymphomas - as secondary therapy in combination with other approved drugs in patients who relapse while being treated with primary therapy, or who fail to respond to primary therapy.

Silvederma Cream 1g/100g Малта - Енглески - Malta Medicines Authority

silvederma cream 1g/100g

laboratorio aldo-union s.l. baronesa de malda 73, 08950 esplugues de llobregat, barcelona, spain - sulfadiazine silver - cream - sulfadiazine silver 1 g - antibiotics and chemotherapeutics for dermatological use

MYOLAXIN 15% SOLUTION FOR INFUSION Ирска - Енглески - HPRA (Health Products Regulatory Authority)

myolaxin 15% solution for infusion

vetoquinol uk limited - guaifenesin - solution for infusion - 15 %w/v - equine non food - neurological preparations

BEKUNIS Израел - Енглески - Ministry of Health

bekunis

dexcel ltd, israel - senna - dragee - senna 150-220 mg - senna glycosides - senna glycosides - laxative.